{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:57:16Z","timestamp":1783486636792,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T00:00:00Z","timestamp":1452643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fondi d\u2019Ateneo from the University of Pisa"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s40618-015-0426-0","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T05:04:48Z","timestamp":1452661488000},"page":"585-591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The presence of anti-thyroglobulin (TgAb) and\/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis"],"prefix":"10.1007","volume":"39","author":[{"given":"L.","family":"Tomisti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Urbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Latrofa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Lupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bartalena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Curzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bogazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"issue":"2","key":"426_CR1","first-page":"240","volume":"22","author":"E Martino","year":"2001","unstructured":"Martino E, Bartalena L, Bogazzi F, Braverman LE (2001) The effects of amiodarone on the thyroid. Endocr Rev 22(2):240\u2013254","journal-title":"Endocr Rev"},{"issue":"5","key":"426_CR2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/105072501300176471","volume":"11","author":"F Bogazzi","year":"2001","unstructured":"Bogazzi F, Bartalena L, Gasperi M, Braverman LE, Martino E (2001) The various effects of amiodarone on thyroid function. Thyroid 11(5):511\u2013519. doi: 10.1089\/105072501300176471","journal-title":"Thyroid"},{"issue":"6","key":"426_CR3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.beem.2009.07.001","volume":"23","author":"SA Eskes","year":"2009","unstructured":"Eskes SA, Wiersinga WM (2009) Amiodarone and thyroid. Best Pract Res Clin Endocrinol Metab 23(6):735\u2013751. doi: 10.1016\/j.beem.2009.07.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"426_CR4","first-page":"340","volume":"35","author":"F Bogazzi","year":"2012","unstructured":"Bogazzi F, Tomisti L, Bartalena L, Aghini-Lombardi F, Martino E (2012) Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest 35(3):340\u2013348. doi: 10.3275\/8298","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"426_CR5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/thy.2010.1635","volume":"20","author":"G Barbesino","year":"2010","unstructured":"Barbesino G (2010) Drugs affecting thyroid function. Thyroid 20(7):763\u2013770. doi: 10.1089\/thy.2010.1635","journal-title":"Thyroid"},{"issue":"6","key":"426_CR6","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","volume":"95","author":"F Bogazzi","year":"2010","unstructured":"Bogazzi F, Bartalena L, Martino E (2010) Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 95(6):2529\u20132535. doi: 10.1210\/jc.2010-0180","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"426_CR7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2265.2004.02119.x","volume":"61","author":"L Bartalena","year":"2004","unstructured":"Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A, Martino E (2004) Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clin Endocrinol (Oxf) 61(4):494\u2013502. doi: 10.1111\/j.1365-2265.2004.02119.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"426_CR8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2265.2006.02590.x","volume":"65","author":"LA Diehl","year":"2006","unstructured":"Diehl LA, Romaldini JH, Graf H, Bartalena L, Martino E, Albino CC, Wiersinga WM (2006) Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. Clin Endocrinol (Oxf) 65(4):433\u2013438. doi: 10.1111\/j.1365-2265.2006.02590.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"426_CR9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1365-2265.2008.03268.x","volume":"69","author":"ML Tanda","year":"2008","unstructured":"Tanda ML, Piantanida E, Lai A, Liparulo L, Sassi L, Bogazzi F, Wiersinga WM, Braverman LE, Martino E, Bartalena L (2008) Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clin Endocrinol (Oxf) 69(5):812\u2013818. doi: 10.1111\/j.1365-2265.2008.03268.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"426_CR10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1210\/jc.2006-2059","volume":"92","author":"F Bogazzi","year":"2007","unstructured":"Bogazzi F, Bartalena L, Tomisti L, Rossi G, Tanda ML, Dell\u2019Unto E, Aghini-Lombardi F, Martino E (2007) Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. J Clin Endocrinol Metab 92(2):556\u2013562. doi: 10.1210\/jc.2006-2059","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"426_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.0300-0664.2001.01457.x","volume":"56","author":"SE Eaton","year":"2002","unstructured":"Eaton SE, Euinton HA, Newman CM, Weetman AP, Bennet WM (2002) Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf) 56(1):33\u201338","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"426_CR12","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1210\/jc.2011-1678","volume":"96","author":"F Bogazzi","year":"2011","unstructured":"Bogazzi F, Bartalena L, Tomisti L, Rossi G, Brogioni S, Martino E (2011) Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study. J Clin Endocrinol Metab 96(11):3374\u20133380. doi: 10.1210\/jc.2011-1678","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"426_CR13","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jc.2002-021874","volume":"88","author":"F Bogazzi","year":"2003","unstructured":"Bogazzi F, Bartalena L, Cosci C, Brogioni S, Dell\u2019Unto E, Grasso L, Aghini-Lombardi F, Rossi G, Pinchera A, Braverman LE, Martino E (2003) Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J Clin Endocrinol Metab 88(5):1999\u20132002. doi: 10.1210\/jc.2002-021874","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"426_CR14","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1210\/jcem.86.10.7976","volume":"86","author":"IJ Chopra","year":"2001","unstructured":"Chopra IJ, Baber K (2001) Use of oral cholecystographic agents in the treatment of amiodarone-induced hyperthyroidism. J Clin Endocrinol Metab 86(10):4707\u20134710. doi: 10.1210\/jcem.86.10.7976","journal-title":"J Clin Endocrinol Metab"},{"issue":"41","key":"426_CR15","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1055\/s-2008-1070506","volume":"106","author":"J Brunn","year":"1981","unstructured":"Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC (1981) Volumetric analysis of thyroid lobes by real-time ultrasound (author\u2019s transl). Dtsch Med Wochenschr 106(41):1338\u20131340. doi: 10.1055\/s-2008-1070506","journal-title":"Dtsch Med Wochenschr"},{"issue":"11","key":"426_CR16","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1089\/thy.1999.9.1069","volume":"9","author":"N Knudsen","year":"1999","unstructured":"Knudsen N, Bols B, Bulow I, Jorgensen T, Perrild H, Ovesen L, Laurberg P (1999) Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 9(11):1069\u20131074","journal-title":"Thyroid"},{"issue":"17","key":"426_CR17","first-page":"1098","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"Mosteller RD (1987) Simplified calculation of body-surface area. N Engl J Med 317(17):1098. doi: 10.1056\/NEJM198710223171717","journal-title":"N Engl J Med"},{"issue":"5","key":"426_CR18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2265.2000.01138.x","volume":"53","author":"JM Gomez","year":"2000","unstructured":"Gomez JM, Maravall FJ, Gomez N, Guma A, Soler J (2000) Determinants of thyroid volume as measured by ultrasonography in healthy adults randomly selected. Clin Endocrinol (Oxf) 53(5):629\u2013634","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"426_CR19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ncpendmet0592","volume":"3","author":"JA Franklyn","year":"2007","unstructured":"Franklyn JA, Gammage MD (2007) Treatment of amiodarone-associated thyrotoxicosis. Nat Clin Pract Endocrinol Metab 3(9):662\u2013666. doi: 10.1038\/ncpendmet0592","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"3","key":"426_CR20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-14-0267","volume":"171","author":"L Tomisti","year":"2014","unstructured":"Tomisti L, Rossi G, Bartalena L, Martino E, Bogazzi F (2014) The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type. Eur J Endocrinol 171(3):363\u2013368. doi: 10.1530\/EJE-14-0267","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"426_CR21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2007.02920.x","volume":"67","author":"F Bogazzi","year":"2007","unstructured":"Bogazzi F, Bartalena L, Dell\u2019Unto E, Tomisti L, Rossi G, Pepe P, Tanda ML, Grasso L, Macchia E, Aghini-Lombardi F, Pinchera A, Martino E (2007) Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Clin Endocrinol (Oxf) 67(4):533\u2013537. doi: 10.1111\/j.1365-2265.2007.02920.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"426_CR22","doi-asserted-by":"crossref","first-page":"E1768","DOI":"10.1210\/jc.2013-2912","volume":"98","author":"F Latrofa","year":"2013","unstructured":"Latrofa F, Fiore E, Rago T, Antonangeli L, Montanelli L, Ricci D, Provenzale MA, Scutari M, Frigeri M, Tonacchera M, Vitti P (2013) Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. J Clin Endocrinol Metab 98(11):E1768\u2013E1774. doi: 10.1210\/jc.2013-2912","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"426_CR23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2265.2011.04008.x","volume":"75","author":"IB Pedersen","year":"2011","unstructured":"Pedersen IB, Knudsen N, Carle A, Vejbjerg P, Jorgensen T, Perrild H, Ovesen L, Rasmussen LB, Laurberg P (2011) A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clin Endocrinol (Oxf) 75(1):120\u2013126. doi: 10.1111\/j.1365-2265.2011.04008.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6646","key":"426_CR24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/bmj.297.6646.456","volume":"297","author":"M Safran","year":"1988","unstructured":"Safran M, Martino E, Aghini-Lombardi F, Bartalena L, Balzano S, Pinchera A, Braverman LE (1988) Effect of amiodarone on circulating antithyroid antibodies. BMJ 297(6646):456\u2013457","journal-title":"BMJ"},{"issue":"2","key":"426_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/acta.0.1210203","volume":"121","author":"V Foresti","year":"1989","unstructured":"Foresti V, Pepe R, Parisio E, Scolari N, Zubani R, Bianco M (1989) Antithyroid antibodies during amiodarone treatment. Acta Endocrinol (Copenh) 121(2):203\u2013206","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"6","key":"426_CR26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40618-014-0083-8","volume":"37","author":"M Rotondi","year":"2014","unstructured":"Rotondi M, Coperchini F, Magri F, Chiovato L (2014) Serum-negative autoimmune thyroiditis: what\u2019s in a name? J Endocrinol Invest 37(6):589\u2013591. doi: 10.1007\/s40618-014-0083-8","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0426-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0426-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0426-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T19:39:34Z","timestamp":1718307574000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0426-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,13]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["426"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0426-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,13]]}}}